These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 15992555

  • 1. Simultaneous use of thyrotropin-releasing hormone test and combined dexamethasone/corticotropine-releasing hormone test for severity evaluation and outcome prediction in patients with major depressive disorder.
    Isogawa K, Nagayama H, Tsutsumi T, Kiyota A, Akiyoshi J, Hieda K.
    J Psychiatr Res; 2005 Sep; 39(5):467-73. PubMed ID: 15992555
    [Abstract] [Full Text] [Related]

  • 2. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.
    Biol Psychiatry; 2007 Jul 01; 62(1):47-54. PubMed ID: 17123470
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb 01; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

  • 4. Social support and enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests in patients with major depressive disorder.
    Tsuru J, Akiyoshi J, Tanaka Y, Matsushita H, Hanada H, Kodama K, Hikichi T, Ohgami H, Tsutsumi T, Isogawa K, Nagayama H.
    Biol Psychol; 2008 May 01; 78(2):159-63. PubMed ID: 18359551
    [Abstract] [Full Text] [Related]

  • 5. Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorder.
    Hikichi T, Akiyoshi J, Ichioka S, Tanaka Y, Tsuru J, Goto S, Matsushita H, Hanada H, Isogawa K, Nagayama H.
    Neuropsychobiology; 2007 May 01; 55(1):21-7. PubMed ID: 17556849
    [Abstract] [Full Text] [Related]

  • 6. Relationships of DEX/CRH and GHRH test results to the outcome of depression--preliminary results suggest the GHRH test may predict relapse after discharge.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    J Psychiatr Res; 2008 Apr 01; 42(5):356-64. PubMed ID: 17412362
    [Abstract] [Full Text] [Related]

  • 7. The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression.
    Veen G, Derijk RH, Giltay EJ, van Vliet IM, van Pelt J, Zitman FG.
    Eur Neuropsychopharmacol; 2009 Jun 01; 19(6):409-15. PubMed ID: 19327969
    [Abstract] [Full Text] [Related]

  • 8. The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after discharge.
    Tsuru J, Ishitobi Y, Ninomiya T, Kanehisa M, Imanaga J, Inoue A, Okamoto S, Maruyama Y, Higuma H, Tanaka Y, Hanada H, Isogawa K, Akiyoshi J.
    Neuro Endocrinol Lett; 2013 Jun 01; 34(5):409-17. PubMed ID: 23922049
    [Abstract] [Full Text] [Related]

  • 9. The combined dexamethasone/CRH test as a potential surrogate marker in depression.
    Ising M, Künzel HE, Binder EB, Nickel T, Modell S, Holsboer F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul 01; 29(6):1085-93. PubMed ID: 15950349
    [Abstract] [Full Text] [Related]

  • 10. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression).
    Appelhof BC, Huyser J, Verweij M, Brouwer JP, van Dyck R, Fliers E, Hoogendijk WJ, Tijssen JG, Wiersinga WM, Schene AH.
    Biol Psychiatry; 2006 Apr 15; 59(8):696-701. PubMed ID: 16368077
    [Abstract] [Full Text] [Related]

  • 11. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr 15; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 12. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan 15; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 13. Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode.
    Gervasoni N, Bertschy G, Osiek C, Perret G, Denis R, Golaz J, Rossier MF, Bondolfi G, Aubry JM.
    J Psychiatr Res; 2004 Jan 15; 38(6):553-7. PubMed ID: 15458850
    [Abstract] [Full Text] [Related]

  • 14. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Weissenburger JE, Fulton CL, Fairchild CJ, Roffwarg HP.
    Biol Psychiatry; 1997 May 01; 41(9):915-28. PubMed ID: 9110097
    [Abstract] [Full Text] [Related]

  • 15. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E, Kartalci S, Tutus A, Turan T, Sofuoglu S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar 01; 28(2):303-9. PubMed ID: 14751427
    [Abstract] [Full Text] [Related]

  • 16. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
    Targum SD.
    Biol Psychiatry; 1984 Mar 01; 19(3):305-18. PubMed ID: 6426529
    [Abstract] [Full Text] [Related]

  • 17. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
    D'Haenen H, Kaufman L, De Weert D, Cornet C, Raets I.
    Acta Psychiatr Belg; 1984 Mar 01; 84(3):228-34. PubMed ID: 6435395
    [Abstract] [Full Text] [Related]

  • 18. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
    Muhtz C, Wester M, Yassouridis A, Wiedemann K, Kellner M.
    J Psychiatr Res; 2008 Jul 01; 42(8):689-93. PubMed ID: 17884095
    [Abstract] [Full Text] [Related]

  • 19. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD.
    Biol Psychiatry; 1983 Jan 01; 18(1):3-19. PubMed ID: 6403062
    [Abstract] [Full Text] [Related]

  • 20. The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in alcoholics.
    Dackis CA, Pottash AL, Bailey J, Stuckey RF, Extein IL, Gold MS.
    NIDA Res Monogr; 1983 Apr 01; 43():266-72. PubMed ID: 6410260
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.